Head-To-Head Review: Isodiol International (OTCMKTS:ISOLF) & MariMed (OTCMKTS:MRMD)

Isodiol International (OTCMKTS:ISOLF) and MariMed (OTCMKTS:MRMD) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, profitability, valuation, institutional ownership, risk, earnings and analyst recommendations.

Insider & Institutional Ownership

0.2% of MariMed shares are held by institutional investors. 19.0% of MariMed shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Isodiol International and MariMed, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Isodiol International	0	0	0	0	0.00
MariMed	0	0	0	1	4.00

Profitability

This table compares Isodiol International and MariMed’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Isodiol International	N/A	N/A	N/A
MariMed	-10.97%	-2.75%	-1.06%

Valuation and Earnings

This table compares Isodiol International and MariMed”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Isodiol International	N/A	N/A	N/A	N/A	N/A
MariMed	$148.60 million	0.37	-$16.03 million	($0.03)	-4.88

Isodiol International has higher earnings, but lower revenue than MariMed.

Summary

MariMed beats Isodiol International on 5 of the 8 factors compared between the two stocks.

About Isodiol International

Isodiol International Inc. engages in the development, marketing, distribution, and sale of hemp-based consumer packaged goods and solutions in Canada and the United States. It develops and manufactures phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. The company offers pharmaceutical grade cannabinoid crystalline isolates derived from exempt parts of the hemp plant, as well as micro-encapsulations and nanotechnology for consumable and topical skin care products. It is also involved in manufacturing and distributing hemp oil and nicotine e-liquids, as well as personal care products; provision of apparel and merchandising solutions; manufactures and sells hemp infused beverages; and supplies pharmaceutical products. The company is headquartered in Vancouver, Canada.

About MariMed

MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature’s Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby’s Baked brand; and drink mix under Vibations brand. It also offers chewable cannabis-infused mint tablet under the brand Kalm Fusion; and flower, vapes, and edibles under InHouse brand. In addition, the company provides supplement, nutrient-infused fruit chews under Betty’s Eddies brand and ice creams under Emack & Bolio’s brand. The company licenses its brands. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.